Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00018824Phase 4Completed
Phase 4, randomised, double-blind trial in alcohol dependence comparing Naltrexone with Placebo (2 arms). Primary endpoint: Alcohol use at 12 weeks. Started Oct 1999; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00018824.